1. Stocks
    2. /
  2. CSL (ASX: CSL)
    3. /

CSL (ASX: CSL) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

CSL Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • CSL (ASX: CSL)
    Latest News

    A woman is excited as she reads the latest rumour on her phone.
    Blue Chip Shares

    These ASX 200 blue chip shares could generate strong returns: brokers

    | James Mickleboro

    Brokers are tipping strong returns from these blue chips over the next 12 months.

    Read more »

    A woman reclines in a comfortable chair while she donates blood holding a pumping toy in one hand and giving the thumbs up in the other as she is attached to a medical machine to collect her blood donation.
    Broker Notes

    Why 12 top brokers say the CSL share price is a no-brainer buy right now

    | Bronwyn Allen

    The ASX 200 blue chip has strong support from a large number of market experts.

    Read more »

    A businessman hugs his computer and smiles.
    Healthcare Shares

    'Exciting growth opportunity'. Why this ASX 200 share is one to buy and hold onto

    | Bernd Struben

    Despite a recent downgrade for FY23, this ASX 200 share still expects to increase its net profits by up to…

    Read more »

    A man sits in deep thought with a pen held to his lips as he ponders his computer screen with a laptop open next to him on his desk in a home office environment.
    Share Market News

    Where can ASX investors find value as interest rates cut into earnings?

    | Tristan Harrison

    The economic picture has completely changed.

    Read more »

    A man with a yellow background makes an annoncement, indicating share price changes on the ASX
    Blue Chip Shares

    Analysts are tipping ~20% returns from these world class ASX 200 blue chip shares

    | James Mickleboro

    Analysts say that these blue chips are top buys right now with big upside.

    Read more »

    A doctor shrugs and holds his hands out.
    Blue Chip Shares

    How much could $10,000 invested in CSL shares be worth next year?

    | James Mickleboro

    Is CSL a good option for investors at current levels?

    Read more »

    How to invest

    I'd use Warren Buffett's advice to aim to beat the ASX 200

    | James Mickleboro

    The Oracle of Omaha has smashed the market over multiple decades. Here's how you could learn from the legendary investor.

    Read more »

    Two happy shoppers finding bargains amongst clothes on a store rack
    Investing Strategies

    'Materially undervalued': 2 popular ASX 200 shares that are long-term bargains now

    | Tony Yoo

    Firetrail analysts believe buying these stocks at the current dip will prove fruitful in the long run.

    Read more »

    Contented looking man leans back in his chair at his desk and smiles.
    Broker Notes

    Top brokers name 3 ASX shares to buy today

    | James Mickleboro

    Lithium, biotech, and fintech are on the menu this week.

    Read more »

    illustration of the words '1 million' in gold with confetti surrounding it
    How to invest

    How quickly could I become an ASX shares millionaire?

    | James Mickleboro

    Want to become a millionaire? Here's how you could achieve this goal.

    Read more »

    A young woman sits at her desk in deep contemplation with her hand to her chin while seriously considering information she is reading on her laptop.
    Healthcare Shares

    Should you jump on CSL shares while they're trading around 52-week lows?

    | Bronwyn Allen

    The CSL share price fell to a new 52-week low of $255.87 earlier this week.

    Read more »

    Share Market News

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    It was another day of red ink on the markets today...

    Read more »

    Frequently Asked Questions

    CSL was listed on the ASX in June 1994.

    CSL has paid twice yearly dividends every year since late 1997, a little over three years after the company’s initial listing on the ASX. Up until early 2005, CSL’s dividends were all fully franked. Since then, franking credits have been intermittent.

    Since 2021 CSL has paid an unfranked interim dividend in April and a 10% franked final dividend in September/October.

    CSL has a dividend reinvestment plan, however, it has not been active since 2004. Instead, CSL periodically executes share buybacks as a way of delivering additional returns for shareholders.

    CSL originally floated in 1994 at $2.30 per share. However, taking into account share buybacks, the adjusted entry price is equivalent to around 76 cents. 

    CSL ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About CSL

    CSL Limited (ASX: CSL) is an Australian-based global biotechnology company that develops and delivers biotherapies and vaccines to protect public health and help people with life-threatening medical conditions live full lives.

    CSL has been in operation for more than a century and was listed on the ASX in 1994. Today, the blue-chip healthcare company is one of the largest on the ASX.

    CSL’s operational businesses include CSL Behring, CSL Seqirus and CSL Vifor. Its Plasma business operates one of the largest plasma collection networks in the world. CSL is recognised for its global leadership in three main areas: rare and serious diseases, vaccine development, and iron deficiency and nephrology (kidney research).

    The company operates in over 40 countries, predominantly Australia, the United States, Germany, the United Kingdom, and Switzerland.

     

    Profile

    since

    Note